PRODUCT

PRODUCT   |  TOXIN  |  MEDITOXIN


MEDITOXIN


  • Safe and durable injectable that, similarly to Botox
  • Temporarily corrects certain types of medium to deep facial wrinkles by relaxing the muscles


MEDITOXIN
Active
Ingredient
Clostridium botulinum toxin type A 
(hall strain)
Unit50 units, 100units, 150units
Storage 
Method

Store in frozen (below -5°C ) or 

refrigeration ( 2-8°C ) condition

Shelf-life
36months from manufacturing date 
(Reconstituted product has a shelf-life of 24 hours in refrigeration condition (2-8°C)
Package Unit
1 vial
Product 
Classification
Prescription Medicine
Product 
Appearance

Injectable lyophilized white powder filled in colorless,

Transparent vial
Indications

•Benign essential blepharospasm in

 adult patients aged 18 years or older.

•Treatment of equines foot deformity due to spasticity in pediatric cerebral

Palsy patients aged 2 years or older.

•Temporary improvement of 

moderate to severe glabellar wrinkles

Associated with corrugators muscle 

and/or procerus muscle activities in 

adults over the age 20 and below the age of 65

•Muscle spasticity : Upper limb spasticity associated with stroke in patients aged 20 or older
PRODUCT

PRODUCT   |  TOXIN  |  MEDITOXIN






MEDITOXIN


  • Safe and durable injectable that, similar to Botox
  • Temporarily corrects certain types of medium to deep facial wrinkles by relaxing the muscles


SPECIFICATION


MEDITOXIN
Active Ingredient
Clostridium botulinum toxin type A (hall strain)
Unit50 units, 100units, 150units, 200units
Storage Method

Store in frozen (below -5°C ) or refrigeration ( 2-8°C ) condition

Shelf-life
36months from manufacturing date ( Reconstituted product has a shelf-life of 24 hours in refrigeration condition (2-8°C)
Package Unit
1 vial
Product Classification
Prescription Medicine
Product Appearance

Injectable lyophilized white powder filled in colorless,

Transparent vial
Indications

•Benign essential blepharospasm in adult patients aged 18 years or older.

•Treatment of equine foot deformity due to spasticity in pediatric cerebral

Palsy patients aged 2 years or older.

•Temporary improvement of moderate to severe glabellar wrinkles

Associated with corrugators muscle and/or procerus muscle activities in adults over the age 20 and below the age of 65

•Muscle spasticity : Upper limb spasticity associated with stroke in patients aged 20 or older
JOHA Meditech Co., Ltd.

W-1205(Hyundai Terrace Tower), 7 Yeonmujang5ga-gil,

Sungdong-gu, Seoul, Korea

CS CENTER

T. +82-2-2223-2129  F. +82-2-2223-2130

E. info@joha.co.kr


Website

Copyright ⓒ JOHA Meditech All righs reserved.

JOHA Meditech Co., Ltd.

HQ  W-1205(Hyundai Terrace Tower), 7 Yeonmujang5ga-gil, Sungdong-gu, Seoul, Korea

CS CENTER

T. +82-2-2223-2129  F. +82-2-2223-2130

E. info@joha.co.kr


Copyright ⓒ JOHA Meditech All righs reserved.